mecamylamine has been researched along with Appetite Disorders in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jerlhag, E | 1 |
| Egecioglu, E | 1 |
| Dickson, SL | 1 |
| Andersson, M | 1 |
| Svensson, L | 1 |
| Engel, JA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of Ghrelin on Alcohol Administration in Non-Treatment Seeking Heavy Drinkers[NCT01779024] | Phase 2 | 17 participants (Actual) | Interventional | 2012-12-13 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The total number of alcohol infusions self-administered. (NCT01779024)
Timeframe: 120 minutes after the start of the infusion
| Intervention | Number of alcohol infusions (Mean) |
|---|---|
| Ghrelin | 10.45 |
| Placebo | 8.80 |
1 other study available for mecamylamine and Appetite Disorders
| Article | Year |
|---|---|
Ghrelin stimulates locomotor activity and accumbal dopamine-overflow via central cholinergic systems in mice: implications for its involvement in brain reward.
Topics: Afferent Pathways; Animals; Brain; Cholinergic Fibers; Dopamine; Feeding and Eating Disorders; Ghrel | 2006 |